| Patent Number |
Title Of Patent |
Date Issued |
| RE38682 |
Grating coupled vertical cavity optoelectronic devices |
January 4, 2005 |
| A edge emitting waveguide laser is obtained that derives its optical power from a vertical cavity laser structure. The vertical cavity laser with top and bottom Distributed Bragg Reflectors produces stimulated emission by resonance in the vertical direction but the optical power so gener |
| PP9466 |
Alstroemeria `Redcoat` |
March 5, 1996 |
| A new and distinct cultivar of Alstroemeria named `Redcoat` is characterized by large rose-red blossoms which have numerous longitudinal maroon/brown streaks on its inner circle of tepals; the top two tepals of this inner group of three also have white and yellow on their lower porti |
| PP9393 |
Alstroemeria `Freedom` |
December 5, 1995 |
| A new and distinct cultivar of Alstroemeria named `Freedom` is characterized by blossoms that have tepals that are coral pink, tipped with green. There are short, thin dark maroon markings along the perimeter of the outer tepals. The inside circle of 3 tepals are the same color at th |
| PP9348 |
Alstroemeria `Patriot` |
October 31, 1995 |
| A new and distinct cultivar of Alstroemeria named `Patriot` is characterized by large purple blossoms which have numerous longitudinal dark purple streaks on its inner circle of tepals; the top two tepals of this inner group of three also have white on their lower portions. The indiv |
| PP9337 |
Alstroemeria `Liberty` |
October 17, 1995 |
| A new and distinct cultivar of Alstroemeria named `Liberty` is characterized by large blossoms that have tepals with central regions of pinkish/purple surrounded by white with numerous dark maroon streaks along the perimeter. The inside circle of 3 tepals are primarily white with num |
| PP17944 |
Panicum plant named `RR1` |
August 28, 2007 |
| A distinct cultivar of Panicum plant named `RR1`, characterized by a base blue-green foliage developing into predominately dark purple-red foliage color by early to mid-summer, easy propagation, vigorous growth and compact growth habit. The unique purple-red color developing at mid-s |
| 7625649 |
Vapor feed fuel cells with a passive thermal-fluids management system |
December 1, 2009 |
| The invention provides a fuel cell system, such as a direct methanol fuel cell (DMFC) that uses passive approaches to thermal-fluids management. In accordance with one embodiment of the invention, a fuel cell is provided that uses a passive fuel delivery system. In accordance with anothe |
| 7589220 |
Inhibitors of the anandamide transporter |
September 15, 2009 |
| Disclosed are compounds that are anandamide transport inhibitors and their pharmacological use. |
| 7578998 |
Chimeric cytokine of IL-7 and beta-chain of HGF and methods of use |
August 25, 2009 |
| The present invention relates to a single-chain or chimeric polypeptide comprising a cytokine and a growth factor linked by at least one amino acid residue, and wherein the chimeric polypeptide enhances the proliferation and/or differentiation of hematopoietic precursor cells. In par |
| 7576580 |
Energy efficient clock deskew systems and methods |
August 18, 2009 |
| Systems and methods for active clock deskew are provided. The disclosed systems/methods advantageously achieve desirable clock deskew at reduced power levels by employing a resistance-based distributed clock deskew technique. The disclosed technique has broad commercial/industrial ap |
| 7563848 |
Crosslinked polycyclooctene |
July 21, 2009 |
| Chemically crosslinked polycyclooctene having excellent shape recovery properties and a method for its synthesis via ring-opening metathesis polymerization of cyclooctene using the dihydroimidazolylidene-modified Grubbs catalyst are disclosed. The polycyclooctene products, following |
| 7536277 |
Intelligent model-based diagnostics for system monitoring, diagnosis and maintenance |
May 19, 2009 |
| Systems and methods are provided for monitoring, diagnosis and condition-based maintenance of mechanical systems. The disclosed systems and methods employ intelligent model-based diagnostic methodologies to effectuate such monitoring, diagnosis and maintenance. According to exemplary |
| 7534933 |
Transgenic plants overexpressing a plant vacuolar H + -ATPase |
May 19, 2009 |
| Transgenic plants are described which are engineered to overexpress vacuolar H.sup.+-PPase. Plants such as tobacco and petunia transformed with A. Thaliana AVP-1 are shown to have increased meristematic activity resulting in larger leaves, stem, flower, fruit, root structures, increa |
| 7520929 |
Gluten biopolymers |
April 21, 2009 |
| This invention consists of a modified gluten biopolymer for use in industrial applications, such as composites and foams. In the present work, the fracture toughness of the gluten polymer was improved with the addition of a thiol-containing modifying agent. This work also resulted in |
| 7447312 |
Method and apparatus for secure ultrafast communication |
November 4, 2008 |
| The present invention describes an ultrafast secure data communication system that can link remote users to an encrypted database with holographic-stored data and a high security and ultrafast transfer rate. |
| 7446229 |
Bicyclic cannabinoids |
November 4, 2008 |
| Bicyclic-cannabinoids and methods of preparation and use are presented. These compounds, when administered in a therapeutically effective amount to an individual or animal, results in a sufficiently high level of that compound in the individual or animal to cause a physiological response |
| 7393842 |
Pyrazole analogs acting on cannabinoid receptors |
July 1, 2008 |
| One aspect of the invention is concerned with cannabimimetic pyrazole analogs. Another aspect of the invention is concerned with new and improved pyrazole analogs having high affinities and/or selectivities for the CB1 cannabinoid receptor. A further aspect of the invention is concer |
| 7378450 |
Aerogel and metallic compositions |
May 27, 2008 |
| Metallic aerogel compositions comprising an aerogel, e.g., RF or carbon aerogel, having metallic particles dispersed on its surface are disclosed. The aerogel compositions can have a uniform distribution of small metallic particles, e.g., 1 nanometer average particle diameter. Also d |
| 7371799 |
Blends of amorphous and semicrystalline polymers having shape memory properties |
May 13, 2008 |
| Blends of amorphous and semicrystalline polymers having shape memory properties were prepared by blending a crystalline polymer such as poly(vinylidene fluoride), polylactide, poly(hydroxxybutyrate), poly(ethylene glycol) polyethylene, polyethylene-co-vinyl acetate, poly(vinyl chlori |
| 7335688 |
Bicyclic cannabinoid agonists for the cannabinoid receptor |
February 26, 2008 |
| Novel polycyclic cannabinoid analogs are presented which have preferentially high affinities for the cannabinoid CB2 receptor sites. The improved receptor affinity makes these analogs therapeutically useful as medications in individuals and animals for treatment of pain, glaucoma, ep |
| 7332223 |
Polymers comprising thieno [3,4-b]thiophene and methods of making and using the same |
February 19, 2008 |
| This invention presents polymers and copolymers comprising repeating units of thieno[3,4-b]thiophene. Water-borne dispersions of such polymers and copolymers can be cast by conventional methods to provide uniform, thin films which possess utility in numerous electroactive applications |
| 7329651 |
Cannabimimetic ligands |
February 12, 2008 |
| Disclosed are heterocyclic compounds and methods for their manufacture. The disclosed compounds are surprisingly potent and selective cannabinoids. Also disclosed are methods of using the disclosed compounds, including use of the disclosed compounds to stimulate a cannabinoid recepto |
| 7285683 |
Bicyclic and tricyclic cannabinoids |
October 23, 2007 |
| Novel bicyclic-cannabinoids and hexahydrocannabinol analogs are presented. These compounds, when administered in a therapeutically effective amount to an individual or animal, results in a sufficiently high level of that compound in the individual or animal to cause a physiological respo |
| 7279547 |
Insecticidal compounds and methods for selection thereof |
October 9, 2007 |
| A series of potent and highly specific insecticidal toxins characterized by an amino acid sequences SEQ ID NO: 2-35. |
| 7276613 |
Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
October 2, 2007 |
| Novel retro-anandamides are presented which have high affinities for the cannabinoid CB1 and/or CB2 receptor sites. Further, most of the analogs exhibit greater metabolic stability than arachidonylethanolamide. The improved receptor affinity and selectivity and/or greater metabolic s |
| 7260501 |
Intelligent model-based diagnostics for system monitoring, diagnosis and maintenance |
August 21, 2007 |
| Systems and methods are provided for monitoring, diagnosis and condition-based maintenance of mechanical systems. The disclosed systems and methods employ intelligent model-based diagnostic methodologies to effectuate such monitoring, diagnosis and maintenance. According to exemplary |
| 7250169 |
Anti-tumor activity of Ea-4-peptide of pro-IGF-1 |
July 31, 2007 |
| Compositions of pro-IFG-I E-peptides for the treatment and amelioration of tumor-producing diseases, and methods for their utilization. |
| 7247707 |
Albumin-free factor VIII formulations |
July 24, 2007 |
| A Factor VIII composition formulated without albumin, comprising the following formulation excipients in addition to Factor VIII: 4% to 10% of a bulking agent selected from the group consisting of mannitol, glycine and alanine; 1% to 4% of a stabilizing agent selected from the group |
| 7247259 |
Processes for making aerogel-electrolyte-metal composites |
July 24, 2007 |
| A process for making an aerogel-electrolyte-metal composite includes contacting an aerogel with an electrolyte to form an aerogel-electrolyte composite; contacting the aerogel-electrolyte composite with a metal precursor to form an aerogel-electrolyte-precursor composite; and convert |
| 7241799 |
Cannabimimetic indole derivatives |
July 10, 2007 |
| Cannabimimetic indole derivatives are presented which have preferentially high affinities for one of the cannabinoid CB1 or CB2 receptor sites. The improved receptor affinity makes these analogs therapeutically useful as medications in individuals and animals. |
| 7212630 |
Method and apparatus for encryption using partial information |
May 1, 2007 |
| A method and apparatus of encrypting optical images using binarization or phase only information is presented with a number of ways to secure the image also being provided. An image to be encrypted is first multiplied by a random phase function. The Fourier transform of the product of th |
| 7186115 |
Advanced thermoplastics for orthodontics |
March 6, 2007 |
| An orthodontic appliance including at least one orthodontic component comprising a thermoplastic polymer. In some embodiments the thermoplastic polymer is a rigid backbone polymer including at least one of a compatibilizing side roup or a solubilizing side group. The thermoplastic po |
| 7183313 |
Keto cannabinoids with therapeutic indications |
February 27, 2007 |
| Novel tricyclic cannabinoid compounds are presented. Some of these compounds exhibit fluorescence properties. The fluorescent cannabinoid compounds are typically endogenously fluorescent. Some of these compounds, when administered in a therapeutically effective amount to an individua |
| 7173106 |
Insecticidal compounds and methods for selection thereof |
February 6, 2007 |
| A potent and highly specific insecticidal toxin comprising 45 residues and three intramolecular disulfide bonds, as well as a method for selecting potent inhibitors of insect calcium channels. |
| 7173096 |
Crosslinked polycyclooctene |
February 6, 2007 |
| Chemically crosslinked polycyclooctene having excellent shape recovery properties and a method for its synthesis via ring-opening methathesis polymerization of cyclooctene using the dihydroimidazolylidene-modified Grubbs catalyst are disclosed. The polycyclooctene products, following |
| 7173027 |
Receptor selective cannabimimetic aminoalkylindoles |
February 6, 2007 |
| Disclosed are cannabimimetic aminoalkylindole compounds and methos for their manufacture. The disclosed compounds are surprisingly potent and selective cannabinoinds. Also disclosed are methods of using the disclosed compounds, including use of the disclosed compounds to stimulate a |
| 7161016 |
Cannabimimetic lipid amides as useful medications |
January 9, 2007 |
| Novel analogs of arachidonylethanolamide are presented which have higher affinities for the cannabinoid CB1 and/or CB2 receptor sites. Further, most of the analogs exhibit greater metabolic stability than arachidonylethanolamide. The improved receptor affinity and selectivity and/or |
| 7151157 |
Mechanically activated shape memory device |
December 19, 2006 |
| A device and method are provided combining the thermal and mechanical attributes of two distinct materials: shape memory materials and super-cooled liquids (SCLs). In one example of the invention, the super-cooled liquid is contained within a shape memory polymer (SCL liquid is fille |
| 7119108 |
Pyrazole derivatives as cannabinoid receptor antagonists |
October 10, 2006 |
| Novel cannabimimetic pyrazole derivatives are presented which have preferentially high affinities for both of the cannabinoid CB1 or CB2 receptor sites. The improved receptor affinity makes these analogs useful as experimental tools for cannabinoid receptor studies as well as clinica |
| 7118752 |
Compositions and methods for inhibiting the proliferation and invasiveness of malignant cells co |
October 10, 2006 |
| A method is described for using an a-type or b-type E domain of the human or trout IGF peptide for the inhibition of proliferation and invasiveness of a broad spectrum of malignant cells and for the inhibition of angiogenesis. The peptide species can be a homologue of the E-domain of |
| 7087723 |
Albumin-free factor VIII formulations |
August 8, 2006 |
| A Factor VIII composition formulated without albumin, comprising the following formulation excipients in addition to Factor VIII: 4% to 10% of a bulking agent selected from the group consisting of mannitol, glycine and alanine; 1% to 4% of a stabilizing agent selected from the group |
| 7071372 |
Method for cloning animals with targetted genetic alterations by transfer of long-term cultured |
July 4, 2006 |
| An improved method of nuclear transfer employing long-term cultured somatic cells as the donor cells and enucleated oocytes as the recipient cells to produce dividing cybrids. Such cybrids are useful for developing viable animals clones when nurtured in a suitable host environment. |
| 7067606 |
Nonionic telechelic polymers incorporating polyhedral oligosilsesquioxane (POSS) and uses thereo |
June 27, 2006 |
| Amphiphilic telechelics incorporating polyhedraloligosilsesquioxane (POSS) synthesized by direct urethane linkage between the diol end groups of polyethylene glycol (PEG) homopolymers and the monoisocyanate group of POSS macromers. The hydrophobicity of the amphiphilic telechelics can be |
| 7057076 |
Bicyclic and tricyclic cannabinoids |
June 6, 2006 |
| Novel bicyclic-cannabinoids and hexahydrocannabinol analogs are presented. These compounds, when administered in a therapeutically effective amount to an individual or animal, results in a sufficiently high level of that compound in the individual or animal to cause a physiological respo |
| 7014837 |
Process for the production of nan-sized zeolite A |
March 21, 2006 |
| Described is a process to synthesize nano-size Zeolite A from an amorphous gel precursor which can be synthesized via reaction of NaAlO.sub.2, NaOH, and tetraethoxysilane (TEOS). Zeolite A with particle sizes of .about.150 nm was made by transformation of the amorphous precursor in ( |
| 6995299 |
Propagation of human hepatocytes in non-human animals |
February 7, 2006 |
| The present invention relates to the preparation of non-human animals having chimeric livers, whereby some or substantially all of the hepatocytes present are human hepatocytes. It is based, at least in part, on the discovery that rats, tolerized in utero against human hepatocytes, w |
| 6995187 |
Peripheral cannabinoid receptor (CB2) selective ligands |
February 7, 2006 |
| Novel polycyclic cannabinoid analogs are presented which have preferentially high affinities for the cannabinoid CB2 receptor sites. The improved receptor affinity makes these analogs therapeutically useful as medications in individuals and animals for treatment of pain, glaucoma, ep |
| 6992317 |
Full color display structures using pseudomorphic cladded quantum dot nanophosphor thin films |
January 31, 2006 |
| This invention discloses novel device structures for full color flat panel displays utilizing pseudomorphically cladded quantum dot nanocrystals. Different colors are obtained by changing the core size and composition of the quantum dots while maintaining a nearly defect-free lattice at |
| 6982172 |
Oocyte vitrification technique |
January 3, 2006 |
| A new method of cryopreservation based on the very fast cooling rates achieved by the direct contact of small droplets of vitrification solution containing biological sample with a very cold solid surface. |
| 6977954 |
Semiconductor laser array device employing modulation doped quantum well structures |
December 20, 2005 |
| An optoelectronic integrated circuit comprises a substrate, a multilayer structure formed on the substrate, and an array of thyristor devices and corresponding resonant cavities formed in the multilayer structure. The resonant cavities, which are adapted to process different wavelengths |
